Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

United Therapeutics Gets Upgrade on Revenue Growth
TheStreet.com
Thursday, January 12, 2012 - 11:01am
tags:
United Therapeutics
30% Safe Upside For Merck, Amgen
Seeking Alpha
Thursday, January 12, 2012 - 10:54am
tags:
Amgen, Merck
Abbott says no bid on rival Pfizer's baby, infant nutrition business
Crain's Chicago Business, IL
Thursday, January 12, 2012 - 9:17am
tags:
Abbott Laboratories, infant nutrition, Pfizer, M&A
Statins Linked to Small Diabetes Risk
ABC News/AP
Thursday, January 12, 2012 - 9:16am
tags:
statins, diabetes
Interferon's Role In Flu Control Shouldn't Be Underestimated
Seeking Alpha
Thursday, January 12, 2012 - 9:11am
tags:
interferon, Flu, Hemispherx, Roche, Novavax, Sinovac
European Scandal Could Help Cytori Therapeutics
Seeking Alpha
Thursday, January 12, 2012 - 9:10am
tags:
Europe, Cytori
KERX Perifosine Analysis
Motley Fool
Thursday, January 12, 2012 - 9:09am
tags:
Keryx, perifosine
Bristol-Myers Squibb: Well Defined Strategy Catalyst For Success
Seeking Alpha
Thursday, January 12, 2012 - 9:08am
tags:
Bristol-Myers Squibb
For Theravance Investors, GlaxoSmithKline Won't Be The Answer
Seeking Alpha
Thursday, January 12, 2012 - 8:30am
tags:
Theravance, GSK, Relovair
Gilead nears completion of Pharmasset deal
Yahoo/AP
Thursday, January 12, 2012 - 8:29am
tags:
M&A, Pharmasset, Gilead
Pradaxa Side Effect Reports Were Hemorrhaging
Pharmalot
Wednesday, January 11, 2012 - 1:04pm
tags:
Pradaxa, Boehringer Ingelheim
$3B or less is Big Pharma's M&A sweet spot
Fierce Pharma
Wednesday, January 11, 2012 - 12:58pm
tags:
M&A, Roche, Sanofi, Bristol-Myers Squibb, Novartis, Pfizer, Merck
Human Genome jumps 12% in midday trading
Marketwatch
Wednesday, January 11, 2012 - 12:54pm
tags:
Human Genome Sciences, Benlysta
Theravance shares make modest rebound
Marketwatch
Wednesday, January 11, 2012 - 12:38pm
tags:
Theravance, Relovair
Teva Gets Upgrade on Revenue Growth
TheStreet.com
Wednesday, January 11, 2012 - 12:00pm
tags:
Teva Pharmaceuticals
Cubist's Preliminary Sales Impress
Yahoo/Zacks.com
Wednesday, January 11, 2012 - 11:59am
tags:
Cubist Pharmaceuticals
Analyst gauges financial loss from Novartis recall
Yahoo/AP
Wednesday, January 11, 2012 - 11:55am
tags:
Novartis, recalls
Can These 5 Pharma Stocks Keep Paying Big Dividends?
Seeking Alpha
Wednesday, January 11, 2012 - 11:55am
tags:
Abbott Laboratories, GSK, Eli Lilly, Merck, Pfizer
A Conflicted FDA Panel, Bayer & Birth Control Pills
Pharmalot
Wednesday, January 11, 2012 - 10:59am
tags:
FDA, Yaz, Yasmin, birth control pill, Bayer
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wednesday, January 11, 2012 - 10:58am
tags:
Celldex, Amgen, Bristol-Myers Squibb, Dendreon, Seattle Genetics, Exelixis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.